store at low temperature | store at -80°C
Demcizumab (OMP 21M18) 是一种抗 DLL4 单克隆抗体。Demcizumab 是一种有效的 Notch 通路抑制剂。Demcizumab 在多种癌症模型中无论使单独还联合化疗试剂使用都是有效的。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 3,730 | 现货 | ||
5 mg | ¥ 7,880 | 现货 | ||
10 mg | ¥ 10,800 | 现货 | ||
25 mg | ¥ 15,900 | 现货 | ||
50 mg | ¥ 21,700 | 现货 | ||
100 mg | ¥ 29,300 | 现货 |
产品描述 | Demcizumab (OMP 21M18) is an anti-DLL4 monoclonal antibody. Demcizumab is a potent Notch pathway inhibitor. Demcizumab is effective in multiple cancer models, both alone and in combination with chemotherapy agents. |
体外活性 |
Demcizumab (0-100 μg/mL) binds to human DLL4 but not to mouse DLL4 and blocks the interaction of DLL4 with the Notch1 receptor in FACS binding assays[3]. Following treatment with Demcizumab at 20 μg/mL for 48 hours, there is a reduction in the mRNA expression of HES1 and DTX1 in PDTALL cells[4]. Demcizumab (0-80 μg/mL, 1, 2, or 3 days) promotes cell death and early apoptosis in PDTALL13 cells[4]. |
体内活性 |
Demcizumab (10 mg/kg, i.p., once weekly) in combination with Irinotecan (7.5 mg/kg) demonstrates a significant antitumor effect in KRASWT and KRASMT colorectal cancer xenograft models[2]. Demcizumab, either alone or in combination with Irinotecan (7.5 mg/kg), is effective against OMP-C8 colon tumors[3]. Administration of Demcizumab (20 mg/kg/week, intraperitoneal injection) increases the survival rate of NRG mice injected with irradiated PDTALL13 cells[4]. |
别名 | OMP 21M18 |
分子量 | 145.65 (kDa) |
CAS No. | 1243262-17-0 |
store at low temperature | store at -80°C
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Demcizumab 1243262-17-0 Neuroscience Proteases/Proteasome Stem Cells Gamma-secretase OMP 21M18 Inhibitor inhibitor inhibit